Skip to content

Opening book details…

About this Medicine article

A phase I trial of a DNA plasmid-based vaccine targeting insulin-like growth factor binding protein-2 (IGFBP-2) in patients with advanced ovarian cancer: Preliminary safety and immunogenicity by Liao, J.B.; Cecil, D.L.; Reichow, J.; Parker, S.; Higgins, D.; Childs, J.; Broussard, E.; Coveler, A.; Salazar, L.; Disis, M.L. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Liao, J.B.; Cecil, D.L.; Reichow, J.; Parker, S.; Higgins, D.; Childs, J.; Broussard, E.; Coveler, A.; Salazar, L.; Disis, M.L.
Publisher
Elsevier Science; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 0090-8258)
Published
2014
Field
Medicine (Health Sciences)

More by Liao, J.B.; Cecil, D.L.; Reichow, J.; Parker, S.; Higgins, D.; Childs, J.; Broussard, E.; Coveler, A.; Salazar, L.; Disis, M.L.

Browse all works by Liao, J.B.; Cecil, D.L.; Reichow, J.; Parker, S.; Higgins, D.; Childs, J.; Broussard, E.; Coveler, A.; Salazar, L.; Disis, M.L.